Withdrawal of MTHFR (C677T mutation) Assay
Following review of services offered across the haematology laboratories of University Hospitals Birmingham, the decision has been made to withdraw the MTHFR (C677T mutation) assay due to its limited clinical utility.
Change to HbA1C reporting in the presence of a Haemoglobin variant.
Please be advised that the Heartlands, Good Hope and Solihull laboratories will no longer be reporting the HbA1C result in the presence of a Haemoglobin variant after Monday 27th March 2023. This will standardise reporting across the UHB network and takes into account the advice from the NICE guidelines (NG28 - 1.6.3).
Please request a fructosamine for monitoring glycamic control for patients who have an abnormal haemoglobin type.